Cancer And Tumor Biomarker-based Assay Market Size, Share & Trends Report

Cancer And Tumor Biomarker-based Assay Market (2025 - 2033) Size, Share & Trends Analysis Report By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer), By Biomarker Type, By End-use, By Region, And Segment Forecasts

Market Segmentation

Cancer And Tumor Biomarker-based Assay Cancer Type Outlook (Revenue, USD Million, 2021 - 2033)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Ovarian Cancer
- Others
Cancer And Tumor Biomarker-based Assay Biomarker Type Outlook (Revenue, USD Million, 2021 - 2033)
- Genetic / Genomic biomarkers
- Protein biomarkers
- Epigenetic biomarkers
- Others
Cancer And Tumor Biomarker-based Assay End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals and Cancer Centers
- Diagnostic Laboratories
- Others
Cancer And Tumor Biomarker-based Assay Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Ovarian Cancer
    - Others
  - North America Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
    - Genetic / Genomic biomarkers
    - Protein biomarkers
    - Epigenetic biomarkers
    - Others
  - North America Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Cancer Centers
    - Diagnostic Laboratories
    - Others
  - U.S.
    - U.S. Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - U.S. Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - U.S. Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Canada
    - Canada Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Canada Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Canada Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Mexico
    - Mexico Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Mexico Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Mexico Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
- Europe
  - Europe Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Ovarian Cancer
    - Others
  - Europe Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
    - Genetic / Genomic biomarkers
    - Protein biomarkers
    - Epigenetic biomarkers
    - Others
  - Europe Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Cancer Centers
    - Diagnostic Laboratories
    - Others
  - UK
    - UK Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - UK Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - UK Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Germany
    - Germany Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Germany Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Germany Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - France
    - France Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - France Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - France Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Spain
    - Spain Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Spain Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Spain Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Italy
    - Italy Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Italy Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Italy Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Denmark
    - Denmark Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Denmark Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Denmark Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Sweden
    - Sweden Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Sweden Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Sweden Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Norway
    - Norway Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Norway Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Norway Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
- Asia Pacific
  - Asia Pacific Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Ovarian Cancer
    - Others
  - Asia Pacific Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
    - Genetic / Genomic biomarkers
    - Protein biomarkers
    - Epigenetic biomarkers
    - Others
  - Asia Pacific Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Cancer Centers
    - Diagnostic Laboratories
    - Others
  - Japan
    - Japan Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Japan Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Japan Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - China
    - China Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - China Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - China Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - India
    - India Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - India Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - India Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Australia
    - Australia Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Australia Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Australia Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - South Korea
    - South Korea Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - South Korea Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - South Korea Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Thailand
    - Thailand Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Thailand Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Thailand Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
- Latin America
  - Latin America Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Ovarian Cancer
    - Others
  - Latin America Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
    - Genetic / Genomic biomarkers
    - Protein biomarkers
    - Epigenetic biomarkers
    - Others
  - Latin America Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Cancer Centers
    - Diagnostic Laboratories
    - Others
  - Brazil
    - Brazil Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Brazil Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Brazil Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Argentina
    - Argentina Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Argentina Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Argentina Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
- MEA
  - MEA Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Prostate Cancer
    - Ovarian Cancer
    - Others
  - MEA Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
    - Genetic / Genomic biomarkers
    - Protein biomarkers
    - Epigenetic biomarkers
    - Others
  - MEA Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
    - Hospitals and Cancer Centers
    - Diagnostic Laboratories
    - Others
  - South Africa
    - South Africa Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - South Africa Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - South Africa Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Saudi Arabia
    - Saudi Arabia Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Saudi Arabia Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Saudi Arabia Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - UAE
    - UAE Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - UAE Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - UAE Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others
  - Kuwait
    - Kuwait Cancer and Tumor Biomarker-based Assay Market, By Cancer Type, (Revenue, USD Million, 2021 - 2033)
      - Breast Cancer
      - Lung Cancer
      - Colorectal Cancer
      - Prostate Cancer
      - Ovarian Cancer
      - Others
    - Kuwait Cancer and Tumor Biomarker-based Assay Market, By Biomarker Type, (Revenue, USD Million, 2021 - 2033)
      - Genetic / Genomic biomarkers
      - Protein biomarkers
      - Epigenetic biomarkers
      - Others
    - Kuwait Cancer and Tumor Biomarker-based Assay Market, By End Use, (Revenue, USD Million, 2021 - 2033)
      - Hospitals and Cancer Centers
      - Diagnostic Laboratories
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments